Mirae Asset Global ETFs Holdings’s Fulcrum Therapeutics FULC Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$100K	Sell	27,325 -755	-3%	-$4.59K	﹤0.01%	2826
2026 Q1	$215K	Buy	28,080 +8,058	+40%	+$74.7K	﹤0.01%	2327
2025 Q4	$226K	Buy	20,022 +16	+0.1%	+$163	﹤0.01%	2296
2025 Q3	$184K	Sell	20,006 -9,427	-32%	-$68.2K	﹤0.01%	2361
2025 Q2	$202K	Sell	29,433 -2,159	-7%	-$11.5K	﹤0.01%	2276
2025 Q1	$91K	Sell	31,592 -4,009	-11%	-$14.7K	﹤0.01%	2679
2024 Q4	$167K	Buy	35,601 +1,520	+4%	+$5.61K	﹤0.01%	2470
2024 Q3	$122K	Buy	+34,081	New	+$253K	﹤0.01%	2615

Other funds holding FULC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's FULC Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Fulcrum Therapeutics (FULC) stake by 2.7% in Q2 2026, selling an estimated $4.59K and leaving 27,325 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #2826.

Mirae Asset Global ETFs Holdings first reported a position in FULC in Q3 2024 and has held it in 8 quarters since. The position peaked at $226K in Q4 2025. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

Mirae Asset Global ETFs Holdings held 27,325 shares of Fulcrum Therapeutics worth $100K as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 755 Fulcrum Therapeutics shares in Q2 2026, an estimated $4.59K.
Fulcrum Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2826 holding.
Mirae Asset Global ETFs Holdings first reported a position in Fulcrum Therapeutics in Q3 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Fulcrum Therapeutics position peaked at $226K in Q4 2025.
155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.